You are on page 1of 15

See

discussions, stats, and author profiles for this publication at:


http://www.researchgate.net/publication/249322532

Electrochemical Deposition of 58SiO 2


-33CaO-9P 2 O 5 Nanobioactive Glass
Particles on Ti-6Al-4V Alloy for
Biomedical Applications

DATASET · JULY 2013

READS

92

5 AUTHORS, INCLUDING:

Saravanakumar Balasubramaniam Judy Gopal


Jeju National University Konkuk University
30 PUBLICATIONS 134 CITATIONS 42 PUBLICATIONS 341 CITATIONS

SEE PROFILE SEE PROFILE

Kamachi Mudali Mudali


Indira Gandhi Centre for Atomic Rese…
414 PUBLICATIONS 2,306 CITATIONS

SEE PROFILE

Available from: Saravanakumar Balasubramaniam


Retrieved on: 01 December 2015
I J A C
Journal Name
1 2 1 2
Manuscript No.
4
B Dispatch: 18.5.13
Author Received:
Journal: IJAC CE: Deepa R
No. of pages: 12 PE: Hariprasad

Int. J. Appl. Ceram. Technol., 1–11 (2013)


DOI:10.1111/ijac.12124

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Electrochemical Deposition of 58SiO2-33CaO-9P2O5
20 Nanobioactive Glass Particles on Ti-6Al-4V Alloy for
21
22 Biomedical Applications
23
24 Balasubramaniam Saravanakumar, Muthusamy Prabhu, and
25 Venkatachalam Rajendran*
26
Centre for Nano Science and Technology, K.S. Rangasamy College of Technology,
27
Tiruchengode 637 215, Tamil Nadu, India
28
29
Judy Gopal and Uthandi Kamachi Mudali
30
31 Corrosion Science and Technology Division, Indira Gandhi Centre for Atomic Research,
32 Kalpakkam 603 102, Tamil Nadu, India
33
34
35
36 The nanobioactive glass (58SiO2-33CaO-9P2O5) powders were synthesized by simple sol–gel method. The prepared
samples reveal amorphous nature, agglomerated spherical morphology with particle size of 100–150 nm. The specific surface
37
area of nanobioactive glass (NBG) particle is 147 m2/g. The NBG samples were coated on titanium (Ti-6Al-4V) alloy
38
through electrochemical deposition method. The particle size of the NBG-coated surface was in the order of 200–300 nm,
39 and it was confirmed by atomic force microscopy (AFM) analysis. In vitro and AFM studies reveal the existence of higher
40 bioactivity and uniform coating of NBG on implants at 80 V for 1 h.
41
42
43 Introduction response at the interface of tissue and materials.1–6 In
44 recent years, nanoscale bioactive materials have
45 Bioactive materials play vital role in biomedical attracted increasing interest because of their enhanced
46 implant applications because of their specific biological bioactivity, which is the result of their increased sur-
47 face-to-volume ratio. The biocompatibility and bone
48 *veerajendran@gmail.com
regeneration properties of bioactive glasses led to their
49 © 2013 The American Ceramic Society use in drug delivery, bone filling, tissue engineering,
2 International Journal of Applied Ceramic Technology—Saravanakumar et al. 2013

1 and antibacterial and medical implant applications.7 coating, the phase nature of the sample was changed,
2 Different materials that show bioactive properties are and the mechanical interface between the metal and
3 glass, glass ceramics, bioglass, calcium phosphate, and glass became weak.29
4 hydroxyapatite.8 The SiO2-CaO-P2O5 glass composi- The aim of this study is to synthesize and charac-
5 tions are obtained by sol–gel method, which directly terize the bioactive glass nanoparticles (SiO2-CaO-
6 leads to the formation of hydroxyapatite layer on the P2O5) using the sol–gel method. The prepared NBG
7 glass surface when contact in simulated body fluid powders are coated on titanium implants using the
8 (SBF) solution. During this period, a series of surface electrochemical anodizing method. The optimum con-
9 reactions take place.9 A reaction on its surface can be ditions for uniform coating of NBG are standardized.
10 described in five sequences. In the first sequence, ion The coating of NBG on implants is characterized using
11 exchange takes place between the glass and SBF. In atomic force microscopy (AFM), epifluorescence
12 the second sequence, the silica network is broken by microscopy, scanning electron microscopy (SEM), and
13 ion exchange, followed by silanol bond formation in transmission electron microcopy (TEM). In addition,
14 the third sequence. The silanol layer has high silica bioactivity of the coated sample is evaluated using in
15 content with a high surface area. During the fourth vitro studies in the simulated body fluid.
16 sequence, the silica-rich layer attracts proteins and col-
17 lagens to form a crystalline hydroxyapatite (HAp)
Experimental Details
18 layer.10 Bioactive glasses are class A biomaterials that
19 possess osteoconductive11 and osteoinductive proper-
Materials
20 ties.12 Properties such as time required for bonding,
21 strength of bonding, and thickness of the interfacial AR grade (Merck, India) chemicals with 99.99%
22 layer depend on the initial composition of materials purity namely, tetraethyl orthosilicate [TEOS; Si
23 and their texture.13 (OC2H5)4], potassium dihydrogen phosphate
24 Bioactive glasses are prepared using different meth- (KH2PO4), calcium nitrate (CaNO34H2O), ammonia
25 ods such as traditional melt quenching14, sol–gel15, solution (min 25% GR), and ultrapure water (Arium
26 and foaming methods.16 The sol–gel method has many 611UF; Sartorius AG, Germany) were used for the 2
27 advantages such as high purity, homogeneity, high sur- preparation of NBG powder.
28 face area, and high osteoconductivity. Further, this is a
29 low-temperature method, and the composition can be
Preparation of nanobioactive glass powders
30 easily varied15,17,18 when compared with other meth-
31 ods. The bioactivity of the glasses prepared by sol–gel Nanobioactive glass powder, namely 58SiO2-
32 method is higher than that of the glasses obtained by 33CaO-9P2O5, was prepared using the sol–gel
33 traditional melt-quenching method. In recent times, method.19,30 The steps involved in the preparation of
34 nanobioactive glass (NBG) powders prepared using the NBG powders are shown in Fig. 1. Initially, TEOS
35 sol–gel method19,20 have been used for implant appli- (9.1 mL) was dissolved in 1:1 ratio of ethanol and ultra-
36 cations because of their high surface area and high bio- pure water. Then, 2 N nitric acid was added to the
37 activity when compared with bulk bioactive solution under stirring for 30 min at room temperature.
38 glasses.21,22 After complete hydrolysis of TEOS, KH2PO4 (1.7 g)
39 Generally, bioactive glass materials have low and CaNO34H2O (5.45 g) salts were dissolved sepa-
40 mechanical strength and are restricted to only low load- rately with 2 mL of distilled water, and the dissolved
41 bearing applications. The mechanical strength of bioac- solution was added to silica solution at 30 min interval
42 tive glasses can be increased by coating on implant under constant stirring at room temperature. After
43 materials. Different methods are used to coat bioactive obtaining the clear solution, 1 M ammonia solution was
44 glass on implants, such as dip coating, laser ablation, added drop wise until the formation of gel, that is, until
45 sputtering, spin coating, anodizing, CO2 laser coating, the solution reaches its pH to ~8.0. Thereafter, the
46 and electrophoretic deposition.23–28 Recently, NBG obtained white gel was dried in a hot air oven at 353 K
47 powders have been coated on a 316L SS substrate for 6 h. The dried gel was calcined at 873 K for 2 h in
48 employing sol–gel dip-coating method for increasing a muffle furnace to remove the carbon and nitrate
49 corrosion resistance and biocompatibility.21 In spray impurities. The calcined samples were ground in a dry
www.ceramics.org/ACT NBG on Ti-6Al-4V Alloy 3 1

1 paper. A DC power supply (Imec, the Netherlands) 3


2 was used for the anodizing process. Voltage was
3 increased from 20 to 110 V with different time inter-
4 vals, namely 1, 2, and 3 h. The increased current was
5 proportional to the applied voltage. The coating
6 process was carried out at room temperature (310 K).
7
8
Optimization of anodizing condition for coating
9
10 Coating parameters such as anodizing time and
11 voltage were optimized (Table I). Coating was carried
12 out at different anodizing times (1, 2, and 3 h) for dif-
13 ferent anodizing voltages such as 20, 50, 80, and
14 110 V. The coated titanium implants were named as
15 T-1, T-2, T-3, and T-4, respectively, for applied
16 coating voltages of 20, 50, 80, and 110 V.
17
18
Characterization studies
19
20 The amorphous nature of NBG powders was
Fig. 1. Nanobioactive glass (NBG) fabrication procedure by
21 investigated through X-ray diffraction (XRD) studies
sol–gel synthesis.
22 using an X-ray diffractometer (D500; Siemens) with 4
23 Cu Ka as a radiation source (k = 1.5418  A). The
24 diffractometer was operated at 40 kV with 2h value
25 ball mill (PM 100; Retsch Corporation, Hann, varying from 0° to 80° with an increment of 0.05°.
26 Germany) at 500 rpm for 1 h to obtain fine bioactive The morphology and microstructure of the NBG
27 glass particles. powders were analyzed by SEM (JSM 6360; JEOL,
28 Tokyo, Japan). The particle size and shape of the pre-
29 pared NBG powders were determined using TEM
Coating of NBG on titanium surface
30 (CM 200; Philips). The surface area of the NBG 5
31 The prepared glass powders were coated on powder was measured using a BET surface area ana-
32 commercial pure (grade 2) titanium (30 mm 9 20 lyzer (Autosorb-1; Quantachrome, Boynton Beach,
33 mm 9 2 mm) using electrochemical anodizing FL). To analyze the sample, we degassed it properly
34 method. Orthophosphoric acid (1 N) was used as an for 3 h at 568 K. The elemental compositions of the
35 electrolyte. A stainless steel cathode was used with tita- NBG powders were measured with the help of
36 nium as an anode. The experimental set up was
37 placed on a magnetic stirrer, and continuous stirring
38 was carried out throughout the anodization process. Table I. Optimization of anodizing condition for
39 Small quantities of NBG powder (1, 2, and 3 g) were
coating of nanobioactive glass (NBG) on Ti implant
40 dissolved in 200 mL electrolyte to establish the effect
41 of initial inoculum of NBG in the electrolyte for Trial Sample Applied
42 improving coating. To remove the oxidation layer on S.No. code weight (g) Time (h) voltage (V)
43 the surface of the titanium implant, it was pickled it
1 T-1 1 1, 2, and 3 20
44 in a solution of HNO3/HF acid bath (400:40 g) for
2 1
45 2 min.31 Thereafter, the implant was cleaned in an
1
46 ultrasonic bath to remove the moisture content. Fur-
2 T-2 3 1 50
47 ther, it was rinsed with ultrapure water and acetone to
3 T-3 3 1 80
48 remove foreign particles from the surface of the tita-
4 T-4 3 1 110
49 nium. Finally, the implant was wiped using a tissue
4 International Journal of Applied Ceramic Technology—Saravanakumar et al. 2013

1 energy-dispersive X-ray analysis (Inca 300; Oxford, when observed under a Nikon Eclipse E600 epifluo-
2 UK). The elements present in the coating were con- rescence microscope (excitation filter BP 490; barrier
3 firmed by field-emission scanning electron microscopy filter O 515). All inorganic compounds appear to
4 (Quanta 200; FEI, Eindhoven, the Netherlands). The fluoresce green. The NBG-modified surfaces exposed
5 surface topography of NBG-coated titanium was char- to the SBF were stained using Acridine Orange for
6 acterized using atomic force microscopy (Solver PRO; 5 min and then washed using distilled water fol-
7 6 NT-MDT, Ireland). lowed by air drying. The green fluorescence film on
8 the surfaces was observed using an epifluorescence
9 microscope.
In vitro studies
10
11 The in vitro study was carried out by dipping the
12 samples in SBF. The NBG-coated titanium sample was Results and Discussion
13 soaked in 75 mL SBF in a sterilized polyethylene con-
14 tainer having almost the same ion concentration and X-ray diffraction patterns of the prepared NBG
15 pH value as that of human blood plasma (Table II). powders are shown in Fig. 2. The observed broad peak
16 The in vitro studies were carried out at 310 K by incu- from 10° to 35° indicates the formation of the Si–O–
17 bating the container in a water bath shaker for 12 days. Si network. It is reported that the amorphous nature of
18 SBF was prepared using AR grade (Merck, India) XRD patterns signifies the internal disorder and glassy
19 chemicals (purity 99.99%) such as NaCl, NaHCO3, nature of the material.34 The result of TEM analysis of
20 KCl, K2HPO43H2O, MgCl26H2O, CaCl2, and the glass powder (shown in Fig. 3a) confirms that the
21 Na2SO4 with ultrapure water (pH 7.2  0.19). Tris- particle size is in the range of 100–150 nm. The
22 hydroxymethyl aminomethane [(CH2OH3)3CNH3] observed particles are agglomerated. However, the
23 and 1 k mol/m3 hydrochloric acid were used to adjust selected area electron diffraction (SAED) pattern (insert
24 the pH value to 7.40.32 The change in the pH value in Fig. 3a) confirms the amorphous nature of the pre-
25 was measured every day using a pH meter (Orion pared NBG particles.35 The specific surface area of the
26 7 5-Star; Thermo Scientific). particles measured from nitrogen adsorption/desorption
27 Acridine Orange, a fluorescent dye, differentially analysis (Fig. 3b) is 147 m2/g. The surface morphology
28 stains single-stranded RNA and double-stranded of the bioactive glass powder is studied using SEM
29 DNA, fluorescing orange when intercalated with the
30 former and green while complexing with the latter33
31
32
33 Table II. Comparison of ion concentration in
34 human blood plasma and simulated body fluid
35
36 Concentration
37 (m mol/dm3)
38 Simulated body human
39 Ion fluid (SBF) blood plasma
40
Na+ 142.0 142.0
41
K+ 5.0 5.0
42
Mg2+ 1.5 1.5
43
Ca2+ 2.5 2.5
44
Cl- 147.8 103.0
45
HCO3- 4.2 4.2
46
HPO42 1.0 1.0
47
SO42 0.5 0.5
48 Fig. 2. X-ray diffraction (XRD) pattern of nanobioactive glass
pH value 7.40 7.40
49 (NBG) powder.
www.ceramics.org/ACT NBG on Ti-6Al-4V Alloy 5 1

1
Colour online, B&W in print

2
3
4
5
6
7
8
9
10
11
12
13
14
15 (a) (b)
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
(c) (d)
31
32 Fig. 3. (a) TEM image, (b) BET plot, (c) SEM image, and (d) EDAX pattern of the nanobioactive glass (NBG) powder.
33
34
35 (Fig. 3c). It shows the agglomeration of the particles. Table III. Comparison of theoretical and
36 The energy-dispersive X-ray analysis spectrum of the experimental composition
37 NBG powder is shown in Fig. 3d, reveals the quantita-
38 tive analysis of the compositional elements Si, P, Ca, Composition (Wt%)
39 and O present in NBG powder. The energy-dispersive Element Theoretical Experimental
40 X-ray analysis spectra result shows the heterogeneous
SiO2 58 59.05
41 distribution of the compositional elements, with the
CaO 33 29.12
42 content of CaO is being less and that of P2O5 being
P2O5 9 11.82
43 relatively higher (Table III).
44 Nanobioactive glass at concentrations of 1, 2, and
45 3 g is dissolved in 200 mL orthophosphoric acid.
46 Anodization is carried out to determine the effect of the AFM image of NBG particles deposited on the
47 the added NBG inoculum on increasing the efficacy surfaces when anodized at 20 V for 1 and 3 h. The
48 of coating. The efficacy of coating of NBG on the above results indicate that there is no increase in coat-
49 titanium plate is revealed by AFM. Fig. 4a,b shows ing efficacy of NBG particles on the surface of
6 International Journal of Applied Ceramic Technology—Saravanakumar et al. 2013

1 titanium with an increase in time, that is, from 1 to for 1 h is shown in Fig. 5. The results reveal that the
2 3 h.36 significant deposition of NBG particles distributed on
3 The AFM image of titanium surface anodized the surface of titanium is obtained using 3 g when
4 with different concentration of NBG particles at 20 V compared with 1 and 2 g NBG-added electrolytes.
5
6
7
Colour online, B&W in print

8 (a) (b)
9
10
11
12
13
14
15
16
17
18
19
20 Fig. 4. Atomic force microscopy (AFM) image of nanobioactive glass (NBG) coating after anodization at 20 V (a) 1 h, (b) 3 h. 9
21
22
23
24
Colour online, B&W in print

(a) (b)
25
26
27
28
29
30
31
32
33
34
35
36 (c)
37
38
39
40
41
42
43
44
45
46
47
48 Fig. 5. Atomic force microscopy (AFM) images of titanium surfaces anodized in different amount of nanobioactive glass (NBG) added 10
49 in electrolytes at 20 V for 1 h (a) 1 g, (b) 2 g, and (c) 3 g.
www.ceramics.org/ACT NBG on Ti-6Al-4V Alloy 7 1

1
Colour online, B&W in print

2
3
4
5
6
7
8
9
10
11
12 (a) (b)
13 Fig. 6. (a) SEM image of uncoated titanium surfaces (b) SEM image of nanobioactive glass (NBG)-coated titanium surfaces anodized
14 at 1 h, at 20 V.
15
16
17 Further, it reveals that the NBG particles coated on
18 the surface are agglomerated when the anodizing volt-
POOR QUALITY FIG

19 age reaches 100 V, which is shown in Fig. 8d. The


20 AFM results confirm that the particle size ranges from
21 200 to 300 nm. Thus, it is inferred from the above
22 studies that optimized coating of NBG on titanium
23 surfaces can be carried out for an anodizing voltage of
24 80 V. The biocompatibility and bioactivity properties
25 of the NBG-coated surface of titanium are studied
26 under the influence of SBF. The SBF-soaked samples
27 are removed at the end of the second and twelfth
28 days.
29 The effect of soaking time on pH value is shown
30 in Fig. 9. It shows the change in pH value in all sam-
31 Fig. 7. EDAX spectrum results of coated surface anodized at 11 ples because of the chemical interactions between the
32 20 V for 1 h. coating and SBF. For the first 3 days, a continuous
33 increase in pH value from its initial value (7.40) is
34 observed in all samples and it is continued for another
35 The SEM image of uncoated and NBG-coated tita- day in sample T-1, which is because of the interchange
36 nium surface anodized at 20 V for 1 h is shown in of Ca2+ ions between the coating and SBF.37 Beyond
37 Fig. 6. The observed results confirm higher deposition this, the pH value decreases on the fourth day for sam-
38 rate at 1 h. Deposition of Si, Ca, and P particles is ples T-2, T-3, and T-4 because of the deficiency of H+
39 found in NBG particles coated on titanium surface, ions in the solution.38 Subsequently, the hydrolysis and
40 which is evident from the energy-dispersive X-ray anal- dissolution of silica take place.39 The dissolution of
41 ysis (Fig. 7). Ca2+ ion and the formation of silanol on the coating
42 In contrast, NBG deposition is increased with an surface are mandatory for the formation of hydroxyapa-
43 increase in anodizing voltage from 20 to 50 V, 50– tite layer on the material surface.40 Silica possesses sur-
44 80 V, and 80–110 V. The gradual increase in NBG face negative charge at physiological pH,41 and this
45 coating as a function of anodizing voltage is evident causes calcium and phosphate ions to form a calcium
46 from Fig. 8. A large number of coatings of NBG par- phosphate-rich layer on the surface of the silica layer.42
47 ticles on the surface of titanium for an anodizing volt- After 5 days, the pH value changes nonlinearly with
48 age of 80 V are noticed. The AFM image (Fig. 8c) soaking time in all coating samples because of leaching
49 supports the observations made from in vitro studies. of the surface crystal.
8 International Journal of Applied Ceramic Technology—Saravanakumar et al. 2013

1
Colour online, B&W in print

(a) (b)
2
3
4
5
6
7
8
9
10
11
12
13 (c) (d)
14
15
16
17
18
19
20
21
22
23
24
25 Fig. 8. Atomic force microscopy (AFM) image showing nanobioactive glass (NBG) deposition as a function of anodizing voltage (a) 12
26 20 V (b) 50 V (c) 80 V, and (d) 110 V.
27
28
29 inorganic layer covering the entire surface is formed on
30 the 80 V/1 h anodized surface after an exposure time
31 of 12 days. The inorganic film that formed on the sur-
32 faces exposed to SBF is reported to be mostly apatite.
33 Fig. 10 shows the increase in the formation of an inor-
34 ganic layer on NBG-modified titanium surfaces. As
35 seen from the Fig. 10, the inorganic layer increases
36 with exposure time in all NBG-modified titanium sur-
37 faces. These results indicate that the NBG-modified
38 surfaces show an increased bioactivity. Initially, there is
39 dissolution of the silicon matrix coating after immer-
40 sion in SBF. Such dissolutions are reported earlier
41 through pulse laser-deposited bioactive glass coat-
42 ings.43–47 The mechanism of apatite formation in bio-
43 active glass is described by Hench8 in four stages, as
44 discussed previously. The increase in apatite formation
Fig. 9. Variation of pH as a function of soaking time.
45 is evident from the epifluorescence micrographs which
46 show an increase in green fluorescence with exposure
47 Epifluorescence microscopy studies for formation time. The in vitro formation of apatite during exposure
48 of inorganic film on the modified titanium surface to SBF is generally accepted as an indicator for in vivo
49 when exposed to SBF show that a dense uniform bioactivity of the material surface.48
www.ceramics.org/ACT NBG on Ti-6Al-4V Alloy 9 1

1
Colour online, B&W in print

(a) (b)
2
3
4
5
6
7
8
9
10 (c) (d)
11
12
13
14
15
16
17
18 (e) (f)
19
20
21
22
23
24
25
26
27 (g) (h)
28
29
30
31
32
33
34
35
Fig. 10. Epifluorescence micrograph of nanobioactive glass (NBG)-modified titanium surface after exposure in SBF (a) 20 V for 2 days,
36
(b) 20 V for 12 days, (c) 50 V for 2 days, (d) 50 V for 12 days, (e) 80 V for 2 days, (f) 80 V for 12 days, (g) 110 V for 2 days, (h)
37 110 V for 12 days.
38
39
40
41 Conclusion of 200–300 nm, and it was confirmed by AFM analy-
42 sis. Bioactivity of the coating of NBG on titanium
43 Silicate glasses with a composition of 58SiO2- implants was analyzed for different time periods (2 and
44 33CaO-9P2O5 were prepared by the sol–gel method. 12 days) in SBF. In vitro and AFM studies reveal the
45 The particle size of the prepared glass powder was in existence of higher bioactivity and uniform coating of
46 the range of 100–150 nm with a surface area of NBG on implants at 80 V for 1 h. These preliminary
47 147 m2/g. NBG powders were successfully coated on results indicate that anodization could be used as a bio-
48 titanium surfaces through an electrochemical deposition active glass coating technique to increase the bioactivity
49 method. The particle size of the NBG was in the order of titanium surfaces.
10 International Journal of Applied Ceramic Technology—Saravanakumar et al. 2013

1 Acknowledgments 20. X. Chen, C. Guo, and N. Zhao, “Preparation and Characterization of


the Sol–Gel Nano-Bioactive Glasses Modified by the Coupling Agent
2 Gamma-Aminopropyltriethoxysilane,” Appl. Surf. Sci., 255 [2], 466–468
3 One of the authors Mr. B. Saravanakumar (2008).
21. M. H. Fathi, and A. Doostmohammadi, “Bioactive Glass Nanopowder
4 acknowledges the summer research fellowship provided and Bioglass Coating for Biocompatibility Improvement of Metallic
5 by the Indian Academy of Sciences, Bangalore. Implant,” J. Mater. Process. Technol., 209 [3], 1385–1391 (2008).
6 22. H. Aguiar, et al., “????????????????,” J. Non- Cryst. Solids, 354 [34], 4075–
4080 (2008). 8
7 23. P. Gonzalez, J. Serra, S. Liste, S. Chiussi, B. Leon, and M. Perez-Amor,
References
8 “Ageing of Pulsed-Laser-Deposited Bioactive Glass Films,” Vacuum, 67
[3–4], 647–651 (2002).
9 1. L. L. Hench, R. J. Splinter, W. C. Allen, and T. K. Greenlee, “Bonding 24. J. H. Park, D. Y. Lee, K. T. Oh, Y. K. Lee, and K. N. Kim, “Bioactive
10 Mechanisms at the Interface of Ceramic Prosthetic Materials,” J. Biomed. Calcium Phosphate Coating on Sodium Hydroxide-Pretreated Titanium
11 Mater. Res., 5 [6], 117–141 (1971). Substrate by Electrodeposition,” J. Am. Ceram. Soc., 87 [9], 792–794
2. H. H. Lu, S. R. Pollack, and P. Ducheyne, “45S5 Bioactive Glass Surface (2004).
12 Charge Variations and the Formation of A Surface Calcium Phosphate 25. C. Garcia, S. Cere, and A. Duran, “Bioactive Coatings Deposited on Tita-
13 Layer in A Solution Containing Fibronectin,” J. Biomed. Res., 54 [45], 4– nium Alloys,” J. Non Cryst. Solids., 352 [32–35], 3488–3495 (2006).
461 (2001). 26. C. Garcia, S. Cere, and A. Duran, “Bioactive Coatings Prepared by Sol–
14 3. Q. Z. Chen, I. D. Thompson, and A. R. Boccaccini, “45S5 Bioglassâ- Gel on Stainless Steel 316L,” J. Non Cryst. Solids, 348 [21], 8–224 (2004).
15 Derived Glass–Ceramic Scaffolds for Bone Tissue Engineering,” Biomateri- 27. E. Gyorgy, et al., “Bioactive Glass and Hydroxyapatite thin Films
als, 27 [11], 2414–2425 (2006). Obtained by Pulsed Laser Deposition,” Appl. Surf. Sci., 253 [19], 7981–
16 4. S. Fujibayashi, M. Neo, H. M. Kim, T. Kokubo, and T. Nakamura, “A 7986 (2007).
17 Comparative Study Between in vivo Bone Ingrowth and in vitro Apatite 28. R. Sindut, et al., “Bioactive Glass Coatings,” J. Mater. Sci., 23 [1], 123–
18 Formation on Na2O–CaO–SiO2 Glasses,” Biomaterials, 24 [8], 1349– 136 (2005).
1356 (2003). 29. J. M. Gomez-Vega, E. Saiz, A. P. Tomsia, G. W. Marshall, and S. J. Mar-
19 5. N. Sooraj Hussain, M. A. Lopes, and J. D. Santos, “A Comparative Study shall, “Bioactive Glass Coatings with Hydroxyapatite and Bioglassâ Parti-
20 of CaO–P2O5–SiO2 Gels Prepared by a Sol–Gel Method,” Mater. Chem. cles on Ti-Based Implants. 1, “Process. Biomater., 21 [10], 5–111 (2000).
Phys., 88 [1], 5–8 (2004). 30. B. Saravanakumar, M. Rajkumar, and V. Rajendran, “Synthesis and Char-
21 6. V. Rajendran, A. Nishara Begum, M. A. Azooz, and F. H. El Batal, acterisation of Nanobioactive Glass for Biomedical Applications,” Mater.
22 “Microstructural Dependence on Relevant Physical-Mechanical Properties Lett., 65 [1], 31–34 (2011).
23 on SiO2-Na2O-CaO-P2O5 Biological Glasses,” Biomaterials, 23 [21], 31. A. Cigada, M. Cabrini, and P. Pedeferri, “Increasing of the Corrosion
4263–4275 (2002). Resistance of the Ti6Al4V Alloy by High Thickness Anodic Oxidation,”
24 7. S. A. Barenberg, “A Bridged Report of the Committee to Survey the J. Mater. Sci., 3 [6], 408–412 (1992).
25 Needs and Opportunities for the Biomaterials Industry,” J. Biomed. Mater. 32. T. Kokubo, H. Kushitani, S. Sakka, T. Kitsugi, and T. Yamamuro, “Solu-
Res., 22 [12], 1267–1291 (1988). tions Able to Reproduce in vivo Surface-Structure Changes in Bioactive
26 8. L. L. Hench, “Bioceramics: From Concept to Clinic,” J. Am. Ceram. Soc., Glass-Ceramic A-W3,” J. Biomed. Mater. Res., 24 [6], 721–734 (1990).
27 74 [7], 1487–1510 (1991). 33. P. A. Tran, L. Sarin, R. H. Hurt, and T. J. Webster, “Opportunities for
28 9. N. Li, Q. Jie, A. Zhu, and R. Wang, “Preparation and Characterization of Nanotechnology-Enabled Bioactive Bone Implants,” J. Mater. Chem., 19
Macroporous Sol–Gel Bioglass,” Ceram. Int., 31 [5], 641–646 (2005). [18], 2653–2659 (2009).
29 10. W. Cao, and L. L. Hench, “Bioactive Materials,” Ceram. Int., 22 [6], 34. J. Wilson, and S. B. Low, “Bioactive Ceramics for Periodontal Treatment:
30 493–507 (1996). Comparative Studies in the Patus Monkey,” J. Appl. Biomater., 3 [12],
11. J. R. Jones, E. Gentleman, and J. Pollak, “Bioactive Glass Scaffolds for 3–129 (1992).
31 Bone Regeneration,” Elements, 3 [6], 393–399 (2007). 35. M. Prabhu, K. Kavitha, P. Manivasakan, V. Rajendran, and P. Kulandaiv-
32 12. S. Lin, C. Ionescu, K. J. Pike, M. E. Smith, and J. R. Jone, “Nanostruc- elu, “Synthesis, Characterization and Biological Response of Magnesium-
ture Evolution and Calcium Distribution in Sol–Gel Derived Bioactive Substituted Nanobioactive Glass Particles for Biomedical Applications,”
33
Glass,” J. Mater. Chem., 19 [9], 1276–1282 (2009). Ceram. Int., 39 [2], 1683–1694 (2013).
34 13. J. Lao, J. M. Nedelec, P. H. Moretto, and E. Jallot, “Micro-PIXE-RBS 36. H. A. Weng, C. C Wu, C. C. Chen, C. C. Ho, and S. J. Ding, “Prepara-
35 Methods Highlighting the Influence of Phosphorus on the in vitro Bioac- tion and Properties of Gold Nanoparticle-Electrodeposited Titanium Sub-
tivity of Sol-Gel Derived Glass Particles in the SiO2-CaO-P2O5 System,” strates with Arg-Gly-Asp-Cys Peptides,” J. Mater. Sci. Mater. Med., 21 [5],
36 Nuclear Instr. Met. Phy. Res, 266 [10], 2412–2417 (2008). 1511–1519 (2010).
37 14. D. Zhao, N. Moritz, E. Vedel, L. Hupa, and H. T. Aro, “Mechanical Ver- 37. S. Roy, and B. Basu, “In vitro Dissolution Behavior of SiO2–MgO–
ification of Soft-Tissue Attachment on Bioactive Glasses and Titanium Al2O3–K2O–B2O3–F Glass–Ceramic System,” J. Mater. Sci. Mater. Med.,
38 Implants,” Acta Biomater., 4 [4], 1118–1122 (2008). 19 [9], 3123–3133 (2008).
39 15. J. Zhong, and D. C. Greenspan, “Processing and Properties of Sol-Gel 38. G. Rajkumar, S. Aravindan, and V. Rajendran, “Structural Analysis of
40 Bioactive Glasses,” J. Biomed. Mater. Res., 53 [6], 694–701 (2000). Zirconia-Doped Calcium Phosphate Glasses,” J. Non- Cryst. Solids, 356
16. M. M. Pereira, J. R. Jones, R. L. Orefice, and L. L. Hench, “Preparation [28–30], 1432–1438 (2010).
41 of Bioactive Glass-Polyvinyl Alcohol Hybrid Foams by the Sol-Gel 39. J. P. Zhong, D. C. Greenspan, L. Sedel, and C. Rey (Eds.), “Bioglassâ
42 Method,” J. Mater. Sci. Mater. Med., 16 [11], 1045–1050 (2005). Surface Reactivity: from in vitro to in vivo,” Biomaterials, 10 391–394
17. M. Laczka, C. Kowalska, A. L. Osyczka, M. Tworzydlo, and B. Turyna, (1997).
43 “Gel-Derived Materials of a CaO-P2O5-SiO2 System Modified by Boron, 40. M. M. Pereira, and L. L. Hench, “Mechanisms of Hydroxyapatite Forma-
44 Sodium, Magnesium, Aluminum, and Fluorine Compounds,” J. Biomed. tion on Porous Gel-Silica Substrates,” J. Sol-Gel. Sci. Technol., 7 [1–2],
45 Mater. Res., 52 [4], 601–612 (2000). 59–68 (1996).
18. J. Lao, J. M. Nedelec, P. H. Moretto, and E. Jallot, “Biological Activity of 41. K. Tsuru, C. Ohtsuki, A. Osaka, T. Iwamoto, and D. J. Mackenzie, “Bio-
46 a SiO2 CaO P2O5 Sol Gel Glass Highlighted by PIXE RBS Methods,” activity of Sol–Gel Derived Organically Modified Silicates: Part I: In vitro
47 Nuclear Instr. Met. Phy. Res. B., 261 [1–2], 488–493 (2007). Examination,” J. Mater. Sci. Mater. Med., 8 [3], 157–161 (1997).
19. W. Xia, and J. Chang, “Preparation and Characterization of Nano-Bioac- 42. M. B. Nair, H. K. Varma, T. V. Kumary, S. Suresh Babu, and A. John,
48 tive-Glasses (NBG) by a Quick Alkali-Mediated Sol–Gel Method,” Mater. “Cell Interaction Studies with Novel Bioglass Coated Hydroxyapatite
49 Lett., 61 [14–15], 3251–3253 (2007). Porous Blocks,” Trends Biomater. Artif. Organs, 19 [2], 108–114 (2006).
www.ceramics.org/ACT NBG on Ti-6Al-4V Alloy 11 1

1 43. M. Ogino, F. Ohuchi, and L. L. Hench, “Compositional Dependence of 46. J. M. Gomez-Vega, E. Saiz, and A. P. Tomsia, “Glass-Based Coatings for
the Formation of Calcium Phosphate Films on Bioglass,” J. Biomed. Mater. Titanium Implant Alloys,” J. Biomed. Mater. Res., 46 [4], 549–559 (1999).
2 Res., 14 [1], 55–64 (1980). 47. S. Fujino, H. Tokunaga, E. Saiz, and A. P. Tomsia, “Fabrication and
3 44. M. W. G. Lockyer, D. Holland, and R. Dupree, “NMR Investigation of Characterization of Bioactive Glass Coatings on Co-Cr Implant Alloys,”
the Structure of Some Bioactive and Related Glasses,” J. Non- Cryst. Solids, Mater. Trans., 45 [4], 1147–1151 (2004).
4 188 [3], 207–219 (1995). 48. H. M. Kim, F. Miyaji, T. Kokubo, and T. Nakamura, “Preparation of
5 45. R. Hill, “An Alternative View of the Degradation of Bioglass,” J. Mater. Bioactive Ti and its Alloys via Simple Chemical Surface Treatment,”
6 Sci. Let, 15 [13], 1122–1125 (1996). J. Biomed. Mater. Res., 32 [3], 409–417 (1996).

7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
Author Query Form
Journal: IJAC
Article: 12124
Dear Author,
During the copy-editing of your paper, the following queries arose. Please respond to these by marking up your
proofs with the necessary changes/additions. Please write your answers on the query sheet if there is insufficient space
on the page proofs. Please write clearly and follow the conventions shown on the attached corrections sheet. If
returning the proof by fax do not write too close to the paper’s edge. Please remember that illegible mark-ups may
delay publication.
Many thanks for your assistance.

Query reference Query Remarks


1 AUTHOR: A running head short title was not supplied; please check if this
one is suitable and, if not, please supply a short title of up to 30 characters
that can be used instead.
2 AUTHOR: Please give address information for Sartorius AG: town, state (if
applicable).
3 AUTHOR: Please give address information for Imec: town, state (if applica-
ble).
4 AUTHOR: Please give address information for Siemens: town, state.
5 AUTHOR: Please give address information for Philips: town, state.
6 AUTHOR: Please give address information for NT-MDT: town, state (if
applicable).
7 AUTHOR: Please give address information for Thermo Scientific: town,
state.
8 AUTHOR: Please provide the article title for reference [22].
9 AUTHOR: Figure 4 is of poor quality. Please check required artwork specifi-
cations at http://authorservices.wiley.com/bauthor/illustration.asp
10 AUTHOR: Figure 5 is of poor quality. Please check required artwork specifi-
cations at http://authorservices.wiley.com/bauthor/illustration.asp
11 AUTHOR: Figure 7 is of poor quality. Please check required artwork specifi-
cations at http://authorservices.wiley.com/bauthor/illustration.asp
12 AUTHOR: Figure 8 is of poor quality. Please check required artwork specifi-
cations at http://authorservices.wiley.com/bauthor/illustration.asp
O n c e y o u h a v e A c r o b a t R e a d e r o p e n o n y o u r c o m p u t e r , c l i c k o n t h e C o m m e n t t a b a t t h e r i g h t o f t h e t o o l b a r :

h i s w i l l o p e n u p a p a n e l d o w n t h e r i g h t s i d e o f t h e d o c u m e n t . h e m a j o r i t o f

T T y

t o o l s o u w i l l u s e f o r a n n o t a t i n g o u r p r o o f w i l l e i n t h e A n n o t a t i o n s s e c t i o n ,
b

y y

p i c t u r e d o p p o s i t e . W e ’ v e p i c k e d o u t s o m e o f t h e s e t o o l s e l o w :
b

S t r i k e s a l i n e t h r o u g h t e x t a n d o p e n s u p a t e x t S t r i k e s a r e d l i n e t h r o u g h t e x t t h a t i s t o e
b

o x w h e r e r e p l a c e m e n t t e x t c a n e e n t e r e d . d e l e t e d .
b b

‚ ‚
i g h l i g h t a w o r d o r s e n t e n c e . i g h l i g h t a w o r d o r s e n t e n c e .

H H

‚ ‚
l i c k o n t h e R e p l a c e ( I n s ) i c o n i n t h e A n n o t a t i o n s l i c k o n t h e S t r i k e t h r o u g h ( D e l ) i c o n i n t h e

C C

s e c t i o n . A n n o t a t i o n s s e c t i o n .


p e t h e r e p l a c e m e n t t e x t i n t o t h e l u e o x t h a t
b b

T y

a p p e a r s .

i g h l i g h t s t e x t i n e l l o w a n d o p e n s u p a t e x t
a r k s a p o i n t i n t h e p r o o f w h e r e a c o m m e n t
M

H y

o x w h e r e c o m m e n t s c a n e e n t e r e d .
b b
n e e d s t o e h i g h l i g h t e d .
b

‚ ‚
i g h l i g h t t h e r e l e v a n t s e c t i o n o f t e x t .
l i c k o n t h e A d d s t i c k n o t e i c o n i n t h e

H
C y

A n n o t a t i o n s s e c t i o n .


l i c k o n t h e A d d n o t e t o t e x t i c o n i n t h e


A n n o t a t i o n s s e c t i o n .
l i c k a t t h e p o i n t i n t h e p r o o f w h e r e t h e c o m m e n t

s h o u l d e i n s e r t e d .
b


p e i n s t r u c t i o n o n w h a t s h o u l d e c h a n g e d
b

T y


r e g a r d i n g t h e t e x t i n t o t h e e l l o w o x t h a t
b
p e t h e c o m m e n t i n t o t h e e l l o w o x t h a t
b

y
T y y

a p p e a r s .
a p p e a r s .
I n s e r t s a n i c o n l i n k i n g t o t h e a t t a c h e d f i l e i n t h e I n s e r t s a s e l e c t e d s t a m p o n t o a n a p p r o p r i a t e

a p p r o p r i a t e p a c e i n t h e t e x t . p l a c e i n t h e p r o o f .

‚ ‚
l i c k o n t h e A t t a c h F i l e i c o n i n t h e A n n o t a t i o n s l i c k o n t h e A d d s t a m p i c o n i n t h e A n n o t a t i o n s

C C

s e c t i o n . s e c t i o n .

‚ ‚
l i c k o n t h e p r o o f t o w h e r e y o u ’ d l i k e t h e a t t a c h e d e l e c t t h e s t a m p y o u w a n t t o u s e . ( T h e A p p r o v e d

C S

f i l e t o b e l i n k e d . s t a m p i s u s u a l l y a v a i l a b l e d i r e c t l y i n t h e m e n u t h a t

a p p e a r s ) .


e l e c t t h e f i l e t o b e a t t a c h e d f r o m y o u r c o m p u t e r


o r n e t w o r k . l i c k o n t h e p r o o f w h e r e y o u ’ d l i k e t h e s t a m p t o

a p p e a r . ( W h e r e a p r o o f i s t o b e a p p r o v e d a s i t i s ,


e l e c t t h e c o l o u r a n d t y p e o f i c o n t h a t w i l l a p p e a r

t h i s w o u l d n o r m a l l y b e o n t h e f i r s t p a g e ) .

i n t h e p r o o f . l i c k O K .

A l l o w s s h a p e s , l i n e s a n d f r e e f o r m a n n o t a t i o n s t o b e d r a w n o n p r o o f s a n d f o r

c o m m e n t t o b e m a d e o n t h e s e m a r k s . .


l i c k o n o n e o f t h e s h a p e s i n t h e D r a w i n g

M a r k u p s s e c t i o n .


l i c k o n t h e p r o o f a t t h e r e l e v a n t p o i n t a n d

d r a w t h e s e l e c t e d s h a p e w i t h t h e c u r s o r .


T o a d d a c o m m e n t t o t h e d r a w n s h a p e ,

m o v e t h e c u r s o r o v e r t h e s h a p e u n t i l a n

a r r o w h e a d a p p e a r s .


D o u b l e c l i c k o n t h e s h a p e a n d t y p e a n y

t e x t i n t h e r e d b o x t h a t a p p e a r s .

You might also like